Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions

NCT00845546 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 10 mg Loratadine/240 mg Pseudoephedrine Sulfate Extended-Release Tablets

Sponsor

Ranbaxy Laboratories Limited